Havel & Partners has advised shareholders Tomas Rutrle, Martin Lips, Yvona Parmova, Martin Slama, and Libor Malek on their sale of IT company Komix to the Cleverlance Group, a subsidiary of the Aricoma Group. Dunovska & Partners advised the buyers on the deal.
Havel & Partners' Partner Frantisek Korbel, acting as a legal representative for the Ceske Radiokomunikace a.s. telecommunications company, has successfully appealed a Czech Supreme Court resolution to the Czech Constitutional Court in a dispute over the removal of the Petrov TV translator station from property owned by the defendant.
Havel & Partners has advised Sebre, Havel & Partners' Managing Partner Jaroslav Havel, and Sebre Managing Director Jan Kubicek, on the joint acquisition of a 50% shareholding in SousedeCZ, a company operating an online platform for digital communication of homeowner associations in residential buildings, from entrepreneurs Tomas Holomoucky and Tomas Sikora.
Noerr has advised facility services provider ISS on the divestment of its main subsidiaries in the Czech Republic, Slovakia, Romania, and Hungary to Hungarian facility management company B+N Referencia Zrt. Havel & Partners advised B+N Referencia on the transaction, which remains contingent on regulatory approval.
New Act No. 37/2021 Sb. on the Register of Beneficial Owners (“ARBO”) will enter into force on 1 June 2021 in the Czech Republic. In contrast to the current legislation, the ARBO introduces significant sanctions for a breach of the obligations it imposes, including fines up to CZK 500,000 or invalidation of voting rights and the right to dividends.
In the Czech Republic, persons who undergo Covid-19 vaccination have been given the opportunity to claim financial compensation from the state if the vaccination (or, more precisely, the medicinal product containing a vaccine) causes harm. The Czech Parliament adopted Act No. 569/2020 Sb., on the Distribution of Medicinal Products Containing a Vaccine for Covid-19 Vaccination and on Compensation for Harm Caused to Those Vaccinated by These Medicinal Products (“Act No. 569/2020 Sb.”), which allows such compensation. According to the explanatory memorandum, this measure aims to “facilitate compensation of those who get vaccinated if they are harmed by the vaccination, thereby also indirectly promoting interest in Covid-19 vaccination.”